Explicating the mystified findings on Dementia

Dario Furnari

University of Exeter, United Kingdom

Abstract

After the successful completion of Dementia 2019, we amiably welcome you afresh for the next series of our Conference entitled “15th World Congress onDementia and Alzheimer’s Disease”, slated on September 02- 03, 2020 in Barcelona, Spain. We are exhilarated to once again welcome all the neuroscience experts to join us in Dementia 2020 to level up your career and stay a step ahead of your peers. This year, we aim to inculcate each and every untouched sector in the field of Dementia and Alzheimer’s Disease with the refreshing theme “Elucidating the latest advancements & cutting-edge research in Dementia and Alzheimer’s Disease”. So, join us to enhance your experiences on the theme of the conference and catalyze the future exchange of knowledge to develop and celebrate a new, dementiafree world! Let's meet and explore in the City of Counts, Barcelona. About Dementia 2020 Dementia covers a wide range of specific medical conditions, including Alzheimer’s disease. Disorders grouped under the general term “dementia” are caused by abnormal brain changes. These changes trigger a decline in thinking skills, also known as cognitive abilities, severe enough to impair daily life and independent function. They also affect behavior, feelings and relationships. Dementia 2020 is designed to meet the needs of both experienced and new career professionals. It would be a gathering of experts from Dementia and Alzheimer’s across the globe. Dementia 2020 will provide great exposure to the new findings in the field of Dementia. It is a wonderful opportunity for all to explore international networking and collaborate with worldclass professionals where we wish to have your gracious presence in our platform. The Majorly Focused Highlights for our Dementia 2020 were Dementia: An Underlying Disease, Alzheimer’s Disease, Parkinson’s Disease, Neurodegenerative Diseases, Vascular Dementia, Traumatic Brain Injury, Neuropharmacology, Neuroep igenetics, Geriatrics Dementia and Cognitive Disorder, Role of Amyloid Protein in Alzheimer’s and Dementia, Diagnosis and Prognosis of Alzheimer’s, Bioinformatics Approach for Dementia, Recent Advancements in the Diagnosis of Dementia, Case Reports in Dementia, Treatment Modalities for Dementia, Alternative treatment for Alzheimer’s, Dementia Care, Practice and Awareness. We welcome all the Dementia professionals, delegates, researchers, and students to make your beautiful presence in Dementia Congress. Reasons to attend Dementia 2020: -Meet eminent experts and personalities working in the field of Neuroscience and Neurology -Enhance your knowledge -Share your innovative ideas - Worldwide Networking and Career Opportunities This platform will give you an international stage to conduct demonstrations, workshops, and symposiums to showcase your services and products. Dementia 2020 will avail you a chance to distribute information and to meet potential national and international delegates. Participants can approach the invited scientists to explore the new product line possibility and exchange ideas of developing novel therapeutics or products. World-renowned speakers, the most recent researches, innovations, and novel updates in the field of Dementia are hallmarks of this Congress. Target Audiences: · Presidents · Directors · Neurologists · Neuroscientists · Neurosurgeons · Neurology Professors · Neurology Assistant and Associate Professors · Postdoctorates and Doctorates · Dementia Researchers · Medical College and Hospitals · Business Entrepreneurs · Training Institutes · Software developing companies · Medical Devices Manufacturing Companies · Dementia community, society and associations · Other experts in Dementia and dementia care Session on: Dementia - An Underlying Disease Dementia is a broad category of brain diseases that causes a long term and often gradual decrease in the ability to think and remember that is great enough to affect a person's daily functioning. Alzheimer’s disease is the most common type of disease which covers 50- 70% cases. The common symptoms of Dementia include emotional constraints, problem in finding words, lack of motivation etc. The severity of Dementia increases with a person’s age. The other common types of diseases which include Dementia are Vascular dementia, Lewy body dementia and Frontotemporal dementia. Worldwide, with Dementia or Related disorders nearly 44 million people have suffered in2015, past results shown 35.66 million population lived with Dementia worldwide in the year 2010, with numbers expected to nearly double each twenty years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, fiftyeight percent of all populations with dementia lived in countries with lower or moderate incomes, with this proportion anticipated to rise to 63% till 2030 and 71% by 2050. This condition is anticipated to double by 2030 and quite triple by 2050 to 115 million. Triumphant completion of 13th World Congress on Dementia and Alzheimer's Disease, Paris, France on September 16-17, 2019 A further conference on Dementia has been successfully completed, we must thank our organizing committee members, keynote speakers, plenary speakers, our young scientists and our delegates for making this dementia congress as a grand success on a pertinent theme of “Exploring the Challenges in the Era of Dementia Research and Care”. We are glad that our attendees had obtained the updated information in the field of dementia, their participation in this conference has been a major step in their career. Some highlighted sessions of Dementia 2019 include Dementia, Alzheimer’s disease, Parkinson’s disease, Neurodegenerative Diseases, Vascular dementia, Neuropharmacology, Neuroepigenetics etc. Organizing committee of Dementia 2019 was Alain Fymat| International Institute of Medicine and Science | USA Alberto Musto | Eastern Virginia Medical School | USA Santiago Restrepo | American University Corporation | Colombia Ian Martins | Edith Cowan University | Australia George N. Shilau | Republican Clinic Medical Center | Russia Dario Furnari | University of Exeter | United Kingdom Notable Participants of Dementia 2019 Jan Ricny | National Institute of Mental Health | Czech Republic Veronica Reaelli | Neurological Institute Carlo Besta | Italy Sandra Garrido | Western Sydney University | Australia Zdenka Kristofikova | National Institute of Mental Health | Czech Republic Elena Vasenina | Russian Medical Academy of Postgraduate Education | Russia Levin Oleg | Russian Medical Academy of Postgraduate Education | Russia Bogolepova Anna | Russian National Research Medical University. N.I. Pirogov | Russia Katunina Elena | Russian National Research Medical University. N.I. Pirogov | Russia Parfenov Vladimir | MGMU them. I.M. Sechenov | Russia Preobrazhenskaya Irina | MSMU them. I.M. Sechenov | Russia Koberskaya Nadezda | MSMU them. I.M. Sechenov | Russia Mkhitaryan Elen | Russian National Research Medical University. N.I. Pirogov | Russia Emelin Andrey | Military Medical Academy named after S.M. Kirov | Russia Lobzin Vladimir | Military Medical Academy named after S.M. Kirov | Russia Soldatkin Viktor | Department of Psychiatry and Narcology FPK and PPS | Russia Marcel Germain | Diex Recherche | Canada Ukharskaia Ekaterina | LLC Merz Pharma | Russia Shatrova Vera | LLC Merz Pharma | Russia Azza A Ali | Al Azhar University | Egypt For this successful completion we should mainly thank our media partners for associating with us. With the grand success of Dementia 2019 AAC proud to announce 14th World Congress on Dementia and Alzheimer's Disease, Spain on September 02-03, 2020 .